Shire Acquisition Provides Company with a Market-Ready Drug
By Sally Mardikian PhD
Pharma Deals Review: Vol 2008 Issue 98 (Table of Contents)
Published: 3 Jul-2008
DOI: 10.3833/pdr.v2008.i98.163 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Shire adds yet another rare disease-targeting drug to its portfolio with its acquisition of Berlin-based Jerini...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS